Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB–IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study
Abstract:ObjectiveRevised staging of patients with locally advanced cervical cancer is based on clinical examination, imaging, and potential surgical findings. A known limitation of imaging techniques is an appreciable rate of understaging. In contrast, surgical staging may provide more accurate information on lymph node involvement. The aim of this prospective study was to evaluate the impact of pre-treatment surgical staging, including removal of bulky lymph nodes, on disease-free survival in patients with locally ad… Show more
“…Thus, laparoscopic staging is widely applied leading to upstaging in > 30% of locally advanced cervical cancer patients and allowing for treatment triage (radical hysterectomy versus definitive RCHT). Recently, the randomized trial Uterus-11 has shown that laparoscopic staging did not only avoid under-or overtreatment, but had an impact on disease-free survival and cancer-specific survival, respectively, without increased toxicity rates [137].…”
This comprehensive review written by experts in their field gives an overview on the current status of incorporating positron emission tomography (PET) into radiation treatment planning. Moreover, it highlights ongoing studies for treatment individualisation and per-treatment tumour response monitoring for various primary tumours. Novel tracers and image analysis methods are discussed. The authors believe this contribution to be of crucial value for experts in the field as well as for policy makers deciding on the reimbursement of this powerful imaging modality.
“…Thus, laparoscopic staging is widely applied leading to upstaging in > 30% of locally advanced cervical cancer patients and allowing for treatment triage (radical hysterectomy versus definitive RCHT). Recently, the randomized trial Uterus-11 has shown that laparoscopic staging did not only avoid under-or overtreatment, but had an impact on disease-free survival and cancer-specific survival, respectively, without increased toxicity rates [137].…”
This comprehensive review written by experts in their field gives an overview on the current status of incorporating positron emission tomography (PET) into radiation treatment planning. Moreover, it highlights ongoing studies for treatment individualisation and per-treatment tumour response monitoring for various primary tumours. Novel tracers and image analysis methods are discussed. The authors believe this contribution to be of crucial value for experts in the field as well as for policy makers deciding on the reimbursement of this powerful imaging modality.
“…The recent results of the prospective trial Uterus-11 showed no differences in OS and PFS globally, although a significant benefit in DFS was found for patients with FIGO stage IIB and, in a post-hoc analysis, a cancer-specific survival benefit in favor of laparoscopic staging (27). However, in this study aortic lymphadenectomy was performed at the same time as pelvic lymphadenectomy, even in those cases that presented bulky pelvic nodes, and therefore the effects only at the pelvic level were not evaluated.…”
on behalf of the Spanish Gynecologic Oncology working Group , Laparoscopic debulking of enlarged pelvic nodes during surgical paraaortic staging in locally advanced cervical cancer: a retrospective comparative cohort study.,
“…A prospective trial evaluated the use of laparoscopic staging after (false) negative FDG-PET/CT and showed significantly superior oncological outcomes for patients with lymph node metastases < 5 mm vs. > 5 mm after surgical staging and RCHT [141]. The shortcoming of the above mentioned Uterus-11 trial [137] is that FDG-PET/CT was not used in that study. The idea of combining the validation of FDG-PET/CT and laparoscopic staging has been discussed by the LilACS study group.…”
Section: Cervical Cancermentioning
confidence: 99%
“…Thus, laparoscopic staging is widely applied leading to upstaging in > 30 % of locally advanced cervical cancer patients and allowing for treatment triage (radical hysterectomy versus definitive RCHT). Recently, the randomized trial Uterus-11 has shown that laparoscopic staging did not only avoid under-or overtreatment, but had an impact on disease-free survival and cancer-specific survival, respectively, without increased toxicity rates [137]. Laparoscopic staging therefore remains the gold standard for FIGO stage IIB and >IIB patients [137][138][139].…”
Section: Cervical Cancermentioning
confidence: 99%
“…Recently, the randomized trial Uterus-11 has shown that laparoscopic staging did not only avoid under-or overtreatment, but had an impact on disease-free survival and cancer-specific survival, respectively, without increased toxicity rates [137]. Laparoscopic staging therefore remains the gold standard for FIGO stage IIB and >IIB patients [137][138][139].…”
This comprehensive review written by experts in their field gives an overview on the current status of incorporating positron emission tomography (PET) into radiation treatment planning. Moreover, it highlights ongoing studies for treatment individualisation and per-treatment tumour response monitoring for various primary tumours. Novel tracers and image analysis methods are discussed. The authors believe this contribution to be of crucial value for experts in the field as well as for policy makers deciding on the reimbursement of this powerful imaging modality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.